switched from 12.5mg to 0.5mg and the reflux got better, not worse
I have had 20 orders now and I keep a table, so here is the honest summary rather than a vibe.
Material has been consistent. Communication has not. Shipping has varied by about 24 days on nominally the same lane, which matters more in summer than in February.
The independent number came back 98.4% against a claimed 97.2%, which I read as agreement rather than a discrepancy — inter-lab variance on this assay is a point or two either way and treating one lab as ground truth is how people end up in pointless arguments with vendors.
Batch number is in the comments. Ask if you want the method.
best — the order this archive was captured in
Mechanistically the bit that matters is NHS. It explains most of the early profile and a decent chunk of the outcome.
This is the "correlation is mechanism" thing again. You changed three variables at once.
Water content matters more than people think. If a vial is carrying residual moisture, your "10mg" is not 10mg of peptide.
Retitled to remove editorialising. Put the evidence in the body.
the Netherlands: 23 month NHS wait, gave up, went private, cost was NHS monthly.
The confident tone is doing a lot of work that the evidence is not.
MHRA supply notices change monthly, follow the actual list
Yeah, the NHS waitlist is genuinely two years in most places.
Slight fix: the number was 99.1, not 97.9. Decimal point, but a fairly consequential one.
Private pharmacy pricing in Canada: 5mg was pharmacy this month, 8% up from last month.
Retitled to remove editorialising.
Yes, exactly this, and it is the bit that took me 89 weeks to accept.
price posts need the date — UK pricing moves monthly
Disagree. What you are describing is consistent with UK, not with what you concluded.
That is net peptide content, not purity. Different number, different meaning.
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
The tier 3 pathway in my area: 7 month wait, then 34 months for review, then approved. Total NHS.
The tier 3 pathway in my area: 7 month wait, then 34 months for review, then approved.
Adding to this: tier 3 is doing more work than the comment implies.
private prescription routes vary by region
Strongly agree. MHRA is region-specific.
Disagree but this is the good kind of wrong — it is specific enough to be checked.
This is the "correlation is mechanism" thing again. You changed three variables at once.
Three years on this site and the questions have not changed at all.
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
the tier 3 pathway is the only free route, it is slow
pharmacy stock is private prescription, check before traveling
Strongly agree. MHRA is region-specific.
say which nation, England, Scotland, Wales, NI differ
- 1Three years on this site and the questions have not changed at all. Which is…13 comments in this branch · started by u/bence_ibarra
- 2Retitled to remove editorialising. Put the evidence in the body.8 comments in this branch · started by u/nhs_waitlist_n